Financial statements Masdrog
Balance sheet data of MASDROG
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 5 506 001,90 | 4 979 169,85 | 4 015 835,63 | 6 884 698,39 | 7 734 448,34 | 8 935 691,19 |
| A. Fixed assets | 824 401,09 | 543 295,50 | 221 896,13 | 128 459,32 | 230 591,73 | 214 691,87 |
| B. Current assets | 4 681 600,81 | 4 435 874,35 | 3 793 939,50 | 6 756 239,07 | 7 503 856,61 | 8 720 999,32 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 5 506 001,90 | 4 979 169,85 | 4 015 835,63 | 6 884 698,39 | 7 734 448,34 | 8 935 691,19 |
| A. Equity | 1 891 626,35 | 3 220 652,09 | 1 460 675,25 | 3 272 952,07 | 3 876 667,99 | 4 408 609,24 |
| B. Liabilities and provisions for liabilities | 3 614 375,55 | 1 758 517,76 | 2 555 160,38 | 3 611 746,32 | 3 857 780,35 | 4 527 081,95 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 3 442 285,34 | 1 681 204,24 | 2 543 273,74 | 3 608 499,92 | 3 856 820,35 | 4 481 972,27 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.